“UCSF is one of the premier cancer centers in the world,” said Linda Ferris, vice president of the Renown Institute for Cancer, in a statement. “The center ranks first in California and seventh nationwide in National Cancer Institute (NCI) research grants, and is home to pioneers in research into genetic, cellular and immune system causes and responses to cancer.”
The partnership will give patients access to a larger pool of cancer experts through joint cancer conferences. For procedures not available at the Renown Institute for Cancer, patients can get express referrals for appointments and treatments at UCSF.
“Treating a disease as complex as cancer requires an integration of skill, expertise and technology,” said Greg Boyer, CEO of Renown Regional Medical Center. “With this new collaboration, patients will be assured of the most advanced treatment available.”
Starting on Jan. 1, 2011, the cancer institute will have access to more than 275 clinical trials.
Renown previously used UCSF for second opinions, said Christos Galanopoulos, medical director of the Renown Institute for Cancer. Galanopoulos, who used to be a faculty member at UCSF, said he pushed for a local partner rather than a national partner so patients would not have to travel far for additional treatment. That way, patients and their families will not have to travel farther than San Francisco.
Galanopoulos stressed that the partnership was more than just a reason to put a UCSF sign on the door. He said it was a truly interactive partnership.
For cancer care, UCSF is the top-ranked medical center in California and eighth in the nation by the U.S. News and World Report Best Hospitals survey. UCSF is one of 40 hospitals accredited by NCI, according to Renown.
The Renown Institute for Cancer is the third affiliate UCSF has partnered with, said Jay Harris, chief strategic planning officer for the UCSF Medical Center. Administrators hope for a total of 12 affiliates.